ArticleScientific reports2022

C-reactive protein to albumin ratio predicts survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib.

Toshifumi Tada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.